Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_assertion description "[Of the five GDPDs tested, GDPD5 was found to be significantly overexpressed in highly malignant estrogen receptor negative (ER(-)) compared with weakly malignant estrogen receptor positive (ER(+)) human breast cancer cells (p = 0.027) and breast tumors from patients (p = 0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_assertion evidence source_evidence_literature NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_assertion SIO_000772 22279038 NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_assertion wasDerivedFrom befree-2016 NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_assertion wasGeneratedBy ECO_0000203 NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.
- befree-2016 importedOn "2016-02-19" NP956151.RAlxCbAjSzT_Zoyl18d2veRnzo2rxUvix8BtTQBUpu6u8130_provenance.